Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System
Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Duminda N. Wijeysundera(St. Michael's Hospital), Biykem Bozkurt(Baylor College of Medicine), Glenn N. Levine(American College of Cardiology), José A. Joglar, Ralph G. Brindis, John S. Ikonomidis(University of North Carolina at Chapel Hill), Joaquin E. Cigarroa(Oregon Health & Science University), Susan J. Pressler, Samuel S. Gidding(Genomic Health (United States)), Sana M. Al‐Khatib(American Heart Association), Lesley H. Curtis(Duke University), Kim K. Birtcher(University of Houston), Lee A. Fleisher(Living Beyond Breast Cancer), Federico Gentile(Mayo Clinic), Mark A. Hlatky(Cardiovascular Institute of the South)
Cited by 290
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
|Journal of the American College of Cardiology|2017|6.5k